OS Therapies Incorporated (OSTX)
NYSEAMERICAN: OSTX · Real-Time Price · USD
1.570
+0.110 (7.53%)
Aug 20, 2026, 4:00 PM EDT - Market closed
OS Therapies Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.21 | 0.27 | 5.53 | 0.04 | 0.17 | 0.08 |
Cash & Short-Term Investments | 0.21 | 0.27 | 5.53 | 0.04 | 0.17 | 0.08 |
Cash Growth | -92.68% | -95.12% | 14095.08% | -77.27% | 112.26% | -93.45% |
Receivables | 3.1 | - | - | - | 0 | 0.23 |
Prepaid Expenses | 0.34 | 0.06 | - | - | - | - |
Other Current Assets | - | - | - | 0.75 | 0.32 | 0 |
Total Current Assets | 3.64 | 0.33 | 5.53 | 0.79 | 0.5 | 0.31 |
Property, Plant & Equipment | 0 | 0 | 0.01 | 0.01 | 0.01 | 0.01 |
Other Intangible Assets | 6.26 | 6.5 | - | - | - | - |
Total Assets | 9.9 | 6.84 | 5.54 | 0.8 | 0.51 | 0.33 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 20.25 | 9.94 | 1.66 | 2.72 | 1.23 | 0.86 |
Accrued Expenses | 0.02 | 1.45 | 0.62 | 2.33 | 1.66 | 0.93 |
Short-Term Debt | - | - | - | 2.48 | - | - |
Current Portion of Long-Term Debt | - | - | - | 12.13 | - | - |
Other Current Liabilities | 0.38 | 0.38 | 2.35 | 5.05 | 3.26 | 1.71 |
Total Current Liabilities | 20.64 | 11.76 | 4.63 | 24.71 | 6.15 | 3.5 |
Long-Term Debt | - | - | - | - | 10.35 | 7.07 |
Long-Term Unearned Revenue | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 | 0.1 |
Other Long-Term Liabilities | - | - | - | - | 1.47 | 1.11 |
Total Liabilities | 20.74 | 11.86 | 4.73 | 24.81 | 18.07 | 11.78 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 0.05 | 0.04 | 0.02 | 0.01 | 0.01 | 0.01 |
Additional Paid-In Capital | 74.26 | 61.05 | 35.14 | 5.5 | 4.03 | 3.76 |
Retained Earnings | -86.22 | -67.19 | -38.43 | -29.52 | -21.6 | -15.22 |
Total Common Equity | -11.91 | -6.1 | -3.27 | -24.02 | -17.56 | -11.45 |
Shareholders' Equity | -10.84 | -5.02 | 0.81 | -24.02 | -17.56 | -11.45 |
Total Liabilities & Equity | 9.9 | 6.84 | 5.54 | 0.8 | 0.51 | 0.33 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Total Debt | - | - | - | 14.61 | 10.35 | 7.07 |
Net Cash (Debt) | 0.21 | 0.27 | 5.53 | -14.57 | -10.18 | -6.99 |
Net Cash Growth | -92.68% | -95.12% | - | - | - | - |
Net Cash Per Share | 0.01 | 0.01 | 0.80 | -2.68 | -1.02 | -0.70 |
Filing Date Shares Outstanding | 46.13 | 39.53 | 21.66 | 11.98 | 10.72 | 10.72 |
Total Common Shares Outstanding | 45.28 | 37.11 | 20.87 | 10.68 | 9.98 | 9.98 |
Working Capital | -17 | -11.43 | 0.91 | -23.92 | -5.65 | -3.18 |
Book Value Per Share | -0.26 | -0.16 | -0.16 | -2.25 | -1.76 | -1.15 |
Tangible Book Value | -18.17 | -12.6 | -3.27 | -24.02 | -17.56 | -11.45 |
Tangible Book Value Per Share | -0.40 | -0.34 | -0.16 | -2.25 | -1.76 | -1.15 |